The m2M project will focus on the controlled, reliable, and precise patterning cellular aggregates and microtissues into large, customizable grafts with programmed structures. The main objective is to develop a platform capable of positioning multiple cellular aggregates or microtissues into stable, durable grafts that can be remodelled into functional tissues once implanted into the body.
The project will bring together leading academic institutions, research centers, and companies to create a system for producing personalised, scalable grafts that can support the repair of damaged tissues.
— We’re thrilled to start working on the micro2MACRO project, which has the potential to make significant advances on the development of osteochondral tissue regeneration therapies. Our goal is to integrate genome editing with state-of-the-art 3D bioprinting modalities and demonstrate the functional advantage of genome-edited inflammation-resistant 3D bioprinted constructs in injured joint-like inflamed environments, said Gonçalo Barreto, PhD, Associate Professor at the University of Helsinki.
Beyond its technical goals, the project will also promote knowledge exchange, workshops and to help advance the skills of researchers and healthcare professionals across Europe.